<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    CohBar, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About CohBar, Inc.

    CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic steatohepatitis (NASH), obesity, Type 2 diabetes (T2D), cancer, cardiovascular disease and CNS disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Steven B. Engle, M.S.
    • FOUNDED
      2007
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Trillium Therapeutics Inc.

    Trillium Therapeutics Inc.

    Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing ...

    Trillium Therapeutics Inc. is a clinical stage ...

    Filing Type:    PU
    Centene Corporation

    Centene Corporation

    Centene Corporation, a Fortune 100 company, is a diversified, multi-national healt...

    Centene Corporation, a Fortune 100 company, is ...

    Filing Type:    PU
    Menlo Therapeutics Inc.

    Menlo Therapeutics Inc.

    We are a late stage biopharmaceutical company focused on the development and comme...

    We are a late stage biopharmaceutical company f...

    Filing Type:    PU
    Spark Therapeutics, Inc.

    Spark Therapeutics, Inc.

    Spark Therapeutics, a fully integrated company, strives to challenge the inevitabi...

    Spark Therapeutics, a fully integrated company,...

    Filing Type:    PU
    Unum Therapeutics Inc.

    Unum Therapeutics Inc.

    Unum Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Unum Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    Alnylam Pharmaceuticals, Inc.

    Alnylam Pharmaceuticals, Inc.

    Alnylam is leading the translation of RNA interference (RNAi) into a whole new cla...

    Alnylam is leading the translation of RNA inter...

    Filing Type:    PU
    Gossamer Bio, Inc.

    Gossamer Bio, Inc.

    Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering,...

    Gossamer Bio is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    ESSA Pharma Inc.

    ESSA Pharma Inc.

    With a focus on the development of small molecule drugs for the treatment of cance...

    With a focus on the development of small molecu...

    Filing Type:    PU
    ProLung, Inc.

    ProLung, Inc.

    ProLung is a medical technology company specializing in innovative predictive anal...

    ProLung is a medical technology company special...

    Filing Type:    PU
    Tandem Diabetes Care, Inc.

    Tandem Diabetes Care, Inc.

    Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the ...

    Tandem Diabetes Care, Inc. is a medical device ...

    Filing Type:    PU
    Midatech Pharma PLC

    Midatech Pharma PLC

    Midatech is an international specialty pharmaceutical company focused on the devel...

    Midatech is an international specialty pharmace...

    Filing Type:    PU
    Nemaura Medical Inc.

    Nemaura Medical Inc.

    Nemaura Medical (NASDAQ:NMRD) is a medical technology company which has developed ...

    Nemaura Medical (NASDAQ:NMRD) is a medical tech...

    Filing Type:    PU
    Milestone Pharmaceuticals Inc.

    Milestone Pharmaceuticals Inc.

    We are a patient-centric, clinical-stage biopharmaceutical company dedicated to br...

    We are a patient-centric, clinical-stage biopha...

    Filing Type:    PU
    PLx Pharma Inc.

    PLx Pharma Inc.

    PLx Pharma Inc. (Nasdaq: PLXP), is a late-stage specialty pharmaceutical company i...

    PLx Pharma Inc. (Nasdaq: PLXP), is a late-stage...

    Filing Type:    PU
    AtriCure, Inc.

    AtriCure, Inc.

    As a leading provider of innovative technologies for the treatment of Atrial Fibri...

    As a leading provider of innovative technologie...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.